Skip to main content

OKX Radar US Stocks Daily Watch: Lego Posts Record Revenue, Inovio's FDA Decision Nears, and Amazon's AI Revenue Is Said to Rely on Anthropic and OpenAI

news By

Lego H1 2026 revenue hit DKK41.9B, up 21%; Inovio's INO-3107 FDA decision Oct 30; Amazon AI revenue seen reliant on Anthropic and OpenAI; research only.

深海军蓝财经编辑封面:以一组逐渐升高的几何数据柱为主视觉焦点,柱体由抽象积木块拼合而成,背景点缀极淡的日历圆环与神经网络节点符号,暗示财报增长、FDA审批与AI收入争议,保留25%干净负空间,不含任何文字或Logo
AI 生成示意图,不代表真实事件现场。
✓

Article Citation Summary

Updated: 2026-09-10 Source: OKX Radar

Lego H1 2026 revenue hit DKK41.9B, up 21%; Inovio's INO-3107 FDA decision Oct 30; Amazon AI revenue seen reliant on Anthropic and OpenAI; research only.

OKX Radar US Stocks Daily Watch

OKX Radar Editorial Team

Guest Columnist

@OKXRadar

August 25, 2026

About 1,300 characters; full read takes about 5 minutes.

Today's observations focus on: Lego's H1 2026 revenue of DKK 41.9 billion, up 21% year over year; Inovio's candidate drug INO-3107 has an FDA decision date approaching October 30; the market questions whether Amazon's AI revenue relies excessively on Anthropic and OpenAI. The following is based on public information and is for research observation reference only.

AI Summary

乐高2026年上半年营收与营业利润对比柱状图,标注具体数值与同比增速

Core view: Lego's latest earnings report shows double-digit growth in both first-half revenue and operating profit; Inovio's PDUFA decision date is approaching, and biopharma regulatory uncertainty is high; analysts note that Amazon's AI revenue relies on circular financing transactions with Anthropic and OpenAI, and attention should be paid to differences in revenue recognition.

Key points:

  • Lego revenue: H1 2026 revenue was DKK 41.9 billion (about USD 6.54 billion), up 21% year over year.
  • Lego operating profit: First-half operating profit was DKK 10.9 billion (about USD 1.7 billion), up 22% year over year.
  • Lego management comments: CEO Niels Christiansen said new partnerships bring new consumers, and both high-priced and low-priced products sold strongly.
  • Inovio regulatory review: Candidate drug INO-3107 targets recurrent respiratory papillomatosis, with a PDUFA decision date of October 30.
  • Amazon AI controversy: Analysts believe Amazon's AI revenue relies heavily on circular financing transactions with Anthropic and OpenAI, and both companies are barely profitable.

[OKX Radar · US Stocks Daily Watch] is a daily US stocks/RWA observation column produced by OKX Radar, an independent third-party information site, aggregating public market information and real news sources, helping readers track important changes in the US stock and RWA tokenization markets; content is for research observation reference only and does not constitute any investment advice.

Lego Record Revenue

Lego's earnings report released on August 25, 2026 showed first-half revenue reached DKK 41.9 billion (about USD 6.54 billion), up 21% year over year, while operating profit grew 22% to DKK 10.9 billion. CEO Niels Christiansen said new partnerships bring new consumers, and both high-priced and low-priced products sold strongly. Lego's record revenue came from simultaneous demand strength across all price bands.

Inovio FDA Decision Approaches

Inovio Pharmaceuticals' candidate drug INO-3107 has a PDUFA decision date set for October 30; the drug targets recurrent respiratory papillomatosis. The regulatory outcome may be approval, a complete response letter, or an extension.

Amazon AI Revenue Controversy

Amazon's AI revenue has been cited by analysts as heavily reliant on circular financing transactions with Anthropic and OpenAI, and both companies are barely profitable; the market is focused on the sustainability of this revenue.

One-Minute Data

  • Lego record revenue: H1 2026 revenue was DKK 41.9 billion (about USD 6.54 billion), up 21% year over year (source: CNBC, 2026-08-25).
  • Lego H1 2026 operating profit: DKK 10.9 billion (about USD 1.7 billion), up 22% year over year (source: CNBC, 2026-08-25).
  • Lego management comments: CEO Niels Christiansen said new partnerships bring new consumers, and high-priced and low-priced products both sold strongly (source: CNBC, 2026-08-25).
  • Inovio regulatory timeline: INO-3107's PDUFA decision date is October 30, targeting recurrent respiratory papillomatosis (source: Seeking Alpha, 2026-08-25).
  • Amazon AI revenue controversy: Analysts note that Amazon's AI revenue relies heavily on circular financing transactions with Anthropic and OpenAI, and both companies are barely profitable (source: Seeking Alpha, 2026-08-25).

OKX Radar's View

Based on the above, Lego's growth data comes from the company's official financial report, but it does not disclose a specific breakdown of currency effects; investors should still pay attention to the subsequent full report and management guidance. Inovio's PDUFA decision is a binary event; historical cases show regulatory outcomes are highly uncertain, and we make no speculation about approval probability. The key to the Amazon AI revenue dependence controversy lies in revenue recognition: direct cloud service revenue, changes in fair value of investments, and circular financing transactions should be viewed separately, and third-party analysis may overlook hedging factors in Amazon's official disclosures. OKX Radar observes only based on public information and does not take any position on OKX products or services.

About OKX Radar

OKX Radar is an independent third-party information site providing OKX announcement interpretation, listing updates, tutorials, fee research, and scenario-based platform comparisons. This article is part of the US Stocks/RWA Daily Watch column and is for informational and research reference only, not investment advice.

References and verification links

These are the article-level sources stored with this page. Interpret dynamic facts and rules in light of their dates, regions, and subsequent updates.

  1. Lego first half 2026 revenue - CNBC
  2. Inovio stock: Final countdown, binary FDA decision - Seeking Alpha
  3. Amazon stock: AI revenue too dependent on OpenAI and Anthropic - Seeking Alpha

FAQ

What is the latest quarter covered by Lego's record revenue report? ▼

H1 2026 report, with revenue of DKK 41.9 billion (about USD 6.54 billion), up 21% year over year.

What is the specific date of Inovio's FDA decision? ▼

Candidate drug INO-3107 has a PDUFA decision date of October 30, targeting recurrent respiratory papillomatosis.

Does Amazon's AI revenue really rely on Anthropic and OpenAI? ▼

Analysts note that Amazon's AI revenue relies heavily on circular financing transactions with Anthropic and OpenAI, and both companies are barely profitable; however, direct revenue, changes in fair value of investments, and cloud service revenue recognition should be distinguished.

What is the cooperation relationship between Anthropic, OpenAI, and Amazon? ▼

Public information shows circular financing transaction relationships exist, but the specific cooperation model should be based on official disclosure.

What is the relationship between the US Stocks Daily Watch and the OKX platform? ▼

This article is a daily observation column of OKX Radar, an independent third-party information site. It is for informational and research reference only, does not constitute investment advice, and does not represent the position of OKX products or services.

Related Insights

View all →
news

OKX Radar US Stock Daily Watch: Lego, Inovio, and Treasury Buybacks: Lego H1 Revenue Up 21% to Record High, Inovio Faces Key FDA Decision

Lego H1 revenue up 21%; Inovio INO-3107 faces FDA ruling Oct 30; ING: Treasury buybacks equal short-term debt financing. Aug 25 data; not investment advice.

news

OKX Radar US Stocks Daily: Nvidia Ends Seven-Day Losing Streak, Marvell Earnings and Treasury Yield Outlook

Nvidia rose 2% ending seven-day losing streak; Marvell earnings may boost AI trade; 10-year Treasury yield 4.623% as of August 2026; not investment advice.

news

OKX Radar US Stocks Daily Watch: Nvidia and Berkshire: Seeking Alpha Strong Buy Rating and AI Risks, Berkshire Shares Fall 6.7% from Highs

On September 2, 2026, OKX Radar sees Nvidia's Strong Buy from Seeking Alpha with a $105B OpenAI liability risk, while Berkshire A drops 6.7% as funds rebalance.

news

OKX Radar US Stocks Daily Watch: Broadcom: Q3 Results Beat Expectations, CEO Expects AI Revenue to Double to $115 Billion

On Sep 3, 2026, Broadcom Q3 EPS of $3.32 and revenue of $29.59B beat LSEG consensus; CEO sees FY2027 AI revenue doubling to $115B, but Q4 guidance missed.

news

OKX Radar US Stocks Daily: FDTX, Newmont, and Lazard International Strategic Equity Portfolio: AI Infrastructure ETF Gets Buy Rating, Gold Giant Downgraded, and International Portfolio Outperforms EAFE in Q2

FDTX gets Buy rating; Newmont Q2 free cash flow $2.2B cut to Hold; Lazard intl portfolio tops MSCI EAFE; market shifts to cash flow and valuation rebalancing.